Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 24.02.2026 FEXD.LN IE00BWTNMB87 458,337.00 USD 42,949,059.55 93.706 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 24.02.2026 FEX.LN IE00B8X9NW27 1,057,271.00 USD 111,372,184.48 105.339 ...
-
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease....
-
Metropolitan Bank Holding Corp. to Host Investor Day on March 3
NEW YORK--(BUSINESS WIRE)--Metropolitan Bank Holding Corp. (the “Company”) (NYSE: MCB), the holding company for Metropolitan Commercial Bank (the “Bank”), a full-service commercial bank based in New York City, announced that it will host an investor day on Tuesday, March 3, 2026, from 9:30 a.m. to 1:30 p.m. ET. The event will feature presentations and Q&A sessions with Founder, President & CEO, Mark DeFazio, EVP & CFO, Dan Dougherty, and other Bank executives covering commercial len...
-
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life‑changing therapies for people living with gastrointestinal (GI) and rare diseases, today reported its fourth quarter and full‑year 2025 results and recent business performance. “In 2025, LINZESS delivered 11% EUTRx demand growth year-over-year, continuing to strengthen its position as the prescription market leader for the treatment of IBS-C and CIC, surpassing 5.7...
-
NexMetro Introduces Private Equity Build-To-Rent Investment Fund for 2026
PHOENIX--(BUSINESS WIRE)--NexMetro's Direct Access Fund offers portfolio of BTR projects in high-growth U.S. markets....
-
Valuedynamx Appoints Eileen Peacock, SVP, General Manager, Valuedynamx U.S. to Lead on Market Expansion
BOSTON--(BUSINESS WIRE)--Valuedynamx, a Collinson Company and leading provider of purchase rewards, today announced that Eileen Peacock has joined as SVP, General Manager, Valuedynamx U.S. With more than 30 years of experience spanning financial services, travel, retail and loyalty, Peacock brings deep sector expertise aligned with Valuedynamx’s strategic priorities. Eileen will lead business development and client services operations to strengthen Valuedynamx's partnerships with airlines, fina...
-
Deep Fission Nuclear Signs Fuel Deal with Urenco USA
BERKELEY, Calif.--(BUSINESS WIRE)--Deep Fission, Inc. (“Deep Fission” or the “Company”), a pioneering advanced nuclear energy company placing small modular pressurized water reactors in boreholes one mile underground, announced today it has entered into an agreement to purchase low-enriched uranium (LEU) from Urenco USA. The fuel will support testing and demonstration activities as part of the Company’s participation in the U.S. Department of Energy’s Reactor Pilot Program as well as early comm...
-
Iron Mountain to Present at Upcoming Financial Conferences
PORTSMOUTH, N.H.--(BUSINESS WIRE)--Iron Mountain Incorporated (NYSE: IRM), a global leader in information management services, announced today that it will present at two upcoming investor conferences: 2026 Morgan Stanley Technology, Media & Telecom Conference Date: Wednesday, March 4, 2026 Time: 8:30 am PT (11:30 am ET) Presenter: Barry A. Hytinen, Executive Vice President and Chief Financial Officer BofA Securities 2026 Information & Business Services Conference Date: Thursday, March...
-
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the Company will participate in a fireside chat at each of the following upcoming investor conferences: TD Cowen 46th Annual Healthcare Conference on Wednesday, March 4, 2026, at 11:10 a.m. EST The Citizens Life Sciences Conference on Wednesday, March 11, 2026, at 10:45 a.m. EST The live audio webcast of each presentation will be accessible on the Investors section of the...